Use of anti-factor xi antibodies for prevention of thrombus formation
AssigneeProthix B.V.
InventorErik HACK
Life of this patent
Estimating the term…
Abstract
The present invention relates to binding molecules such as antibodies that specifically bind plasma coagulation factor XI and that inhibit factor XI activation and/or activity. The factor XI-binding molecules of the invention may used in methods for preventing or treating diseases, disorders and/or conditions that are mediated by factor XI activation and/or wherein inhibition of factor XI has a beneficial effect.
Claims14
A binding molecule that specifically binds factor XI and inhibits factor XI activity, for use in preventing or treating a disease, disorder and/or condition that is mediated by factor XI activation and/or wherein inhibition of factor XI has a beneficial effect.
Dependencies are inferred from the claim text.